Account-creators
1,040
edits
Difference between revisions of "Estrogen receptor"
Jump to navigation
Jump to search
Undo revision 48550 by Jensflorian (talk) -sorry
Jensflorian (talk | contribs) (Undo revision 48550 by Jensflorian (talk) -sorry) |
|||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{ Infobox immunostain | |||
| Name = {{PAGENAME}} | |||
| Image = Stomach Metastatic Breast Carcinoma, IHC for Estrogen Receptor (5610737866).jpg | |||
| Width = | |||
| Caption = ER+ve in metastatic breast carcinoma. | |||
| Abbrev = ER | |||
| Synonyms = | |||
| Similar = | |||
| Clones = | |||
| Use = | |||
| Subspecial = | |||
| Pattern = nuclear staining | |||
| Positive = Breast and endometrial carcinoma | |||
| Negative = | |||
| Other = | |||
}} | |||
'''Estrogen receptor''', abbreviated '''ER''', is a common [[immunostain]]. | '''Estrogen receptor''', abbreviated '''ER''', is a common [[immunostain]]. | ||
| Line 13: | Line 30: | ||
**[[Invasive ductal carcinoma of the breast]] - most. | **[[Invasive ductal carcinoma of the breast]] - most. | ||
*[[Endometrial carcinoma]]s. | *[[Endometrial carcinoma]]s. | ||
* PRL-producing [[pituitary adenoma]]s (Prolactioma)<ref>{{Cite journal | last1 = Delgrange | first1 = E. | last2 = Vasiljevic | first2 = A. | last3 = Wierinckx | first3 = A. | last4 = François | first4 = P. | last5 = Jouanneau | first5 = E. | last6 = Raverot | first6 = G. | last7 = Trouillas | first7 = J. | title = Expression of estrogen receptor alpha is associated with prolactin pituitary tumor prognosis and supports the sex-related difference in tumor growth. | journal = Eur J Endocrinol | volume = 172 | issue = 6 | pages = 791-801 | month = Jun | year = 2015 | doi = 10.1530/EJE-14-0990 | PMID = 25792376 }}</ref> | |||
===Occasionally positive=== | ===Occasionally positive=== | ||